A fully integrated, multi-layer AI architecture designed for the biological complexity of modern drug discovery.
Most AI tools in drug discovery address a single stage in isolation. Prognica Labs built a fully integrated platform where each layer informs and amplifies the others — creating compounding intelligence across the entire discovery workflow.
Data Ingestion &
Harmonisation Layer
Multi-Omics AI
Integration Engine
Proprietary generative models trained on 120M+ compounds produce novel, synthesizable molecules optimized across multiple drug-like properties simultaneously, moving beyond analog-based medicinal chemistry.
Ensemble ML models predict ADMET properties, binding affinity, selectivity, and PK/PD parameters with validated accuracy across >85% of endpoints, reducing in vitro and in vivo screening burden significantly.
Every prediction in our platform is accompanied by mechanistic rationale – attention maps, feature importance scores, and biological pathway annotations – enabling scientific trust and regulatory confidence.
An intelligent workflow engine connects all platform components into automated, adaptive discovery loops – routing compounds and targets through the right analyses at the right time, minimizing manual handoffs.
Contact us with your own compound or disease target for a demo.
Copyright © 2025 Prognica Labs, All Rights Reserved
Trust & Security || Terms of Use || Privacy Policy || Cookies Policy